Harston, United Kingdom

Ian Walker

This inventor holds 1 USPTO granted patent. Top assignee: Acacia Pharma Limited. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ian Walker. Retrieved from https://idiyas.com/inventor/ian-walker-muxjni9w

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ian Walker - Innovator in Pharmaceutical Formulations

Introduction

Ian Walker is a notable inventor based in Harston, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of xerostomia, commonly known as dry mouth. His innovative approach has led to the development of a unique formulation that enhances patient care.

Latest Patents

Ian Walker holds a patent for the "Use of bethanechol for treatment of Xerostomia." This formulation is designed for topical administration and comprises bethanechol along with a penetration enhancer. The formulation is preferably maintained in the buccal cavity for a period of time prior to being swallowed, providing an effective solution for individuals suffering from dry mouth.

Career Highlights

Ian Walker is associated with Acacia Pharma Limited, where he applies his expertise in pharmaceutical development. His work focuses on creating innovative solutions that address unmet medical needs. His dedication to improving patient outcomes is evident in his research and development efforts.

Collaborations

Ian collaborates with Michael John Frodsham, leveraging their combined expertise to advance their projects and enhance the effectiveness of their formulations.

Conclusion

Ian Walker's contributions to the field of pharmaceuticals, particularly through his patent on the treatment of xerostomia, highlight his commitment to innovation and improving patient care. His work at Acacia Pharma Limited continues to pave the way for advancements in pharmaceutical formulations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…